These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 12351525

  • 1. In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome.
    Cheung AP, Pride SM, Yuen BH, Sy L.
    Hum Reprod; 2002 Oct; 17(10):2540-7. PubMed ID: 12351525
    [Abstract] [Full Text] [Related]

  • 2. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
    De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, De Palo R, Ranieri A, Colacurci N, Mollo A, Italian Collaborative Group on Recombinant Human Luteinizing Hormone.
    Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
    [Abstract] [Full Text] [Related]

  • 3. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R, Buckler HM, Matson P, Lieberman B, Burger HG, Hilton B, Horne G, Dyson M, Robertson WR.
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [Abstract] [Full Text] [Related]

  • 4. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S, Spanish Collaborative Group on Female Hypogonadotrophic Hypogonadism.
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [Abstract] [Full Text] [Related]

  • 5. Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial.
    NyboeAndersen A, Humaidan P, Fried G, Hausken J, Antila L, Bangsbøll S, Rasmussen PE, Lindenberg S, Bredkjaer HE, Meinertz H, Nordic LH study group.
    Hum Reprod; 2008 Feb; 23(2):427-34. PubMed ID: 18024487
    [Abstract] [Full Text] [Related]

  • 6. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F, Scarinci E, Palla C, Romani F, Familiari A, Tropea A, Leoncini E, Lanzone A, Apa R.
    Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
    [Abstract] [Full Text] [Related]

  • 7. The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: a prospective randomized controlled study.
    Younis JS, Izhaki I, Ben-Ami M.
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):99-106. PubMed ID: 26304041
    [Abstract] [Full Text] [Related]

  • 8. LH improves early follicular recruitment in women over 38 years old.
    Gómez-Palomares JL, Acevedo-Martín B, Andrés L, Ricciarelli E, Hernández ER.
    Reprod Biomed Online; 2005 Oct; 11(4):409-14. PubMed ID: 16274596
    [Abstract] [Full Text] [Related]

  • 9. Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome.
    McCartney CR, Bellows AB, Gingrich MB, Hu Y, Evans WS, Marshall JC, Veldhuis JD.
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E902-8. PubMed ID: 14736706
    [Abstract] [Full Text] [Related]

  • 10. Comparison of two different starting doses of recombinant follicle stimulating hormone (rFSH) for intrauterine insemination (IUI) cycles in non-obese women with polycystic ovary syndrome (PCOS): a retrospective cohort study.
    Seckin B, Yumusak OH, Tokmak A.
    J Obstet Gynaecol; 2021 Nov; 41(8):1234-1239. PubMed ID: 33624571
    [Abstract] [Full Text] [Related]

  • 11. Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome: a systematic review based on a Cochrane review.
    van Wely M, Bayram N, van der Veen F.
    Hum Reprod; 2003 Jun; 18(6):1143-9. PubMed ID: 12773438
    [Abstract] [Full Text] [Related]

  • 12. Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.
    Suikkari AM, MacLachlan V, Montalto J, Calderon I, Healy DL, McLachlan RI.
    Hum Reprod; 1995 Mar; 10(3):513-9. PubMed ID: 7782424
    [Abstract] [Full Text] [Related]

  • 13. The effect of rLH supplementation to the GnRH-antagonist protocol on endocrine dynamics in the advanced reproductive age.
    Younis JS, Izhaki I, Ben-Ami M.
    J Endocrinol Invest; 2017 Aug; 40(8):831-839. PubMed ID: 28290093
    [Abstract] [Full Text] [Related]

  • 14. Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome.
    van Wely M, Bayram N, van der Veen F, Bossuyt PM.
    Hum Reprod; 2005 Jul; 20(7):1827-32. PubMed ID: 15831514
    [Abstract] [Full Text] [Related]

  • 15. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G, Agirregoikoa JA, Jiménez MR, de Larruzea AL, Ganzabal T, Carbonero K.
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [Abstract] [Full Text] [Related]

  • 16. The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries.
    Barnes RB, Namnoum AB, Rosenfield RL, Layman LC.
    Hum Reprod; 2002 Jan; 17(1):88-91. PubMed ID: 11756367
    [Abstract] [Full Text] [Related]

  • 17. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L, Hall JE, Potau N, Carrascosa A, Prat N, Taylor AE.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [Abstract] [Full Text] [Related]

  • 18. The effect of recombinant LH on embryo quality: a randomized controlled trial in women with poor ovarian reserve.
    Musters AM, van Wely M, Mastenbroek S, Kaaijk EM, Repping S, van der Veen F, Mochtar MH.
    Hum Reprod; 2012 Jan; 27(1):244-50. PubMed ID: 22095792
    [Abstract] [Full Text] [Related]

  • 19. Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome.
    Wachs DS, Coffler MS, Malcom PJ, Shimasaki S, Chang RJ.
    J Clin Endocrinol Metab; 2008 May; 93(5):1827-33. PubMed ID: 18285408
    [Abstract] [Full Text] [Related]

  • 20. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation.
    De Placido G, Alviggi C, Mollo A, Strina I, Ranieri A, Alviggi E, Wilding M, Varricchio MT, Borrelli AL, Conforti S.
    Clin Endocrinol (Oxf); 2004 May; 60(5):637-43. PubMed ID: 15104569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.